|
|||||
|
|
Novel TIE‐2 inhibitor BAY‐826 displays in vivo efficacy in experimental syngeneic murine glioma models |
|
| Authors: | Hannah Schneider Emese Szabo Raquel A. C. Machado Angela Broggini‐Tenzer Alexander Walter Mario Lobell Dieter Heldmann Frank Süssmeier Sylvia Grünewald Michael Weller |
| Affiliation: | 1. Laboratory of Molecular Neuro‐Oncology, Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland;2. Laboratory for Molecular Radiobiology, Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland;3. GTRG Oncology II, Drug Discovery, Bayer Pharma AG, Berlin, Germany;4. Medicinal Chemistry, Drug Discovery, Bayer Pharma AG, Wuppertal, Germany;5. Center for Neuroscience, University of Zurich, Zurich, Switzerland |
| Abstract: | |
| Keywords: | BAY‐826 glioma irradiation syngeneic TIE‐2 inhibition |